Skip to content
HowShorted

CorMedix Inc. short interest in 2024

In 2024, CorMedix Inc.'s disclosed short interest ran from 12.86% of shares outstanding on 12 Jan 2024 to 11.54% on 31 Dec 2024, a change of -1.32 percentage points. The year's high was 18.84% on 15 Jul 2024 and its low 10.36% on 31 Oct 2024, averaging 15.36% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.86 days on 29 Feb 2024. Full history: CorMedix Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CorMedix Inc. in 2024

2024 in figures

Start of year
12.86% (12 Jan 2024)
End of year
11.54% (31 Dec 2024)
Change
-1.32 pp
High
18.84% (15 Jul 2024)
Low
10.36% (31 Oct 2024)
Average
15.36%
Highest days to cover
26.86 (29 Feb 2024)
SEC filings marked
8

Every report in 2024

CorMedix Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202412.86%18.30
31 Jan 202413.12%17.75
15 Feb 202414.10%17.82
29 Feb 202414.08%26.86
15 Mar 202414.18%11.8010-K filed, results (8-K)
28 Mar 202415.04%21.12
15 Apr 202417.06%9.22
30 Apr 202417.93%14.87
15 May 202417.62%13.6110-Q filed, results (8-K)
31 May 202417.89%20.47
14 Jun 202418.13%22.67
28 Jun 202417.85%18.21
15 Jul 202418.84%24.11
31 Jul 202418.55%20.00
15 Aug 202418.47%13.7710-Q filed, results (8-K)
30 Aug 202418.10%13.28
13 Sep 202418.59%10.02
30 Sep 202416.59%9.85
15 Oct 202414.07%7.92
31 Oct 202410.36%3.5410-Q filed, results (8-K)
15 Nov 202411.27%5.39
29 Nov 202411.36%7.32
13 Dec 202411.09%7.96
31 Dec 202411.54%7.79

See also: CorMedix Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.